These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12775588)
21. [Communication and transparency concerning risk-benefit analysis in public health: the example of medication]. Lehner JP; Meyer F; Juillet Y Therapie; 2001; 56(4):335-9. PubMed ID: 11677849 [TBL] [Abstract][Full Text] [Related]
22. [How to improve drug information!]. Järhult B Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057 [No Abstract] [Full Text] [Related]
24. A standard of knowledge for pharmaceutical sales representatives. Bootman JL Manag Care Interface; 2006 Oct; 19(10):13. PubMed ID: 17117593 [No Abstract] [Full Text] [Related]
25. Better communication urged for pharmaceutical manufacturers. Woods D Can Med Assoc J; 1984 Jun; 130(11):1488-9. PubMed ID: 6733620 [No Abstract] [Full Text] [Related]
29. Key opinion leaders: used as a marketing tool by drug companies. Prescrire Int; 2012 Jun; 21(128):163-5. PubMed ID: 22822596 [TBL] [Abstract][Full Text] [Related]
30. Patient information leaflets--helpful guidance or a source of confusion? Bjerrum L; Foged A Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848 [TBL] [Abstract][Full Text] [Related]
31. Responses from pharmaceutical companies to doctors' requests for more drug information in Pakistan: postal survey. Hafeez A; Mirza Z BMJ; 1999 Aug; 319(7209):547. PubMed ID: 10463894 [No Abstract] [Full Text] [Related]
33. "Compendium of pharmaceuticals and specialties". Geekie DA Can Med Assoc J; 1977 Apr; 116(7):710. PubMed ID: 849545 [No Abstract] [Full Text] [Related]
34. EC, don't let drug companies give information to the public. Currie JA; Preston H; Weerapperuma S BMJ; 2009 Jan; 338():b290. PubMed ID: 19174440 [No Abstract] [Full Text] [Related]
35. No more free lunches: doctors and journals in the South cut off drug companies at their peril. Ana J BMJ; 2003 Aug; 327(7410):341-2. PubMed ID: 12907496 [No Abstract] [Full Text] [Related]
37. Clinical drug information profit or knowledge orientated. Worthen DB Ethics Sci Med; 1976 Dec; 3(4):235-45. PubMed ID: 1031666 [No Abstract] [Full Text] [Related]
38. [Presentation of results of research in medical journals. Observations based on an in-depth analysis of articles on experimental toxicology]. Gerday R Bull Soc Sci Med Grand Duche Luxemb; 1979; 116(1):69-78. PubMed ID: 544093 [No Abstract] [Full Text] [Related]
39. An assessment of future training needs for PhD graduates for European pharmaceutical companies: a report from the committee on industrial relations (CIR) of EUFEPS. European Federation for Pharmaceutical Sciences. Eur J Pharm Sci; 1999 Feb; 7(3):iii-v. PubMed ID: 10048939 [No Abstract] [Full Text] [Related]